---
abstract: ''
authors:
- Slawson, David C
category: Clinical Review
clinical_significance: High
cme_credits: 0.0
doi: ''
evidence_level: ''
external_resources:
- title: PubMed Entry
  type: reference
  url: https://pubmed.ncbi.nlm.nih.gov/37725472/
file_path: 2023/09/treat-to-target-ldl-strategy-of-statin-dosing-is-noninferior.md
issue: '3'
keywords:
- Hydroxymethylglutaryl-CoA Reductase Inhibitors
- Humans
last_updated: '2025-08-09'
mesh_terms:
- Humans
- Hydroxymethylglutaryl-CoA Reductase Inhibitors
original_format: PubMed
pages: Online
patient_population: Adults
peer_reviewed: true
pmid: '37725472'
processed_date: '2025-08-09'
publication_date: '2023-09-01'
pubmed_enriched: true
pubmed_enriched_date: '2025-08-09'
reading_time_minutes: 1
source: American family physician
specialties:
- Family Medicine
status: processed
tags:
- clinical-review
- family-practice
- clinical-medicine
- pubmed-enhanced
title: Treat-to-Target LDL Strategy of Statin Dosing Is Noninferior to High-Intensity
  Dosing.
topics:
- Family Medicine
volume: '108'
publication_types: &id001
- Journal Article
pubmed_content_enriched: true
pubmed_full_data:
  pmid: '37725472'
  title: Treat-to-Target LDL Strategy of Statin Dosing Is Noninferior to High-Intensity
    Dosing.
  authors:
  - last_name: Slawson
    fore_name: David C
    initials: DC
    affiliation: Atrium Health, Charlotte, N.C.
  journal_info:
    title: American family physician
    iso_abbreviation: Am Fam Physician
    volume: '108'
    issue: '3'
  publication_info:
    year: '2023'
    month: 09
    full_date: '2023-09-01'
  article_ids: {}
  mesh_terms:
  - descriptor: Humans
    major_topic: false
  - descriptor: Hydroxymethylglutaryl-CoA Reductase Inhibitors
    major_topic: true
    qualifiers:
    - qualifier: therapeutic use
      major_topic: false
  publication_types: *id001
related_articles:
- pmid: '37725472'
  title: Treat-to-Target LDL Strategy of Statin Dosing Is Noninferior to High-Intensity
    Dosing.
  authors:
  - name: Slawson DC
    authtype: Author
    clusterid: ''
  source: Am Fam Physician
  pubdate: 2023 Sep
- pmid: '36877807'
  title: 'Treat-to-Target or High-Intensity Statin in Patients With Coronary Artery
    Disease: A Randomized Clinical Trial.'
  authors:
  - name: Hong SJ
    authtype: Author
    clusterid: ''
  - name: Lee YJ
    authtype: Author
    clusterid: ''
  - name: Lee SJ
    authtype: Author
    clusterid: ''
  - name: Hong BK
    authtype: Author
    clusterid: ''
  - name: Kang WC
    authtype: Author
    clusterid: ''
  - name: Lee JY
    authtype: Author
    clusterid: ''
  - name: Lee JB
    authtype: Author
    clusterid: ''
  - name: Yang TH
    authtype: Author
    clusterid: ''
  - name: Yoon J
    authtype: Author
    clusterid: ''
  - name: Ahn CM
    authtype: Author
    clusterid: ''
  - name: Kim JS
    authtype: Author
    clusterid: ''
  - name: Kim BK
    authtype: Author
    clusterid: ''
  - name: Ko YG
    authtype: Author
    clusterid: ''
  - name: Choi D
    authtype: Author
    clusterid: ''
  - name: Jang Y
    authtype: Author
    clusterid: ''
  - name: Hong MK
    authtype: Author
    clusterid: ''
  - name: LODESTAR Investigators
    authtype: CollectiveName
    clusterid: ''
  source: JAMA
  pubdate: 2023 Apr 4
- pmid: '31367867'
  title: 'Statin Dosing Instructions, Medication Adherence, and Low-Density Lipoprotein
    Cholesterol: a Cohort Study of Incident Statin Users.'
  authors:
  - name: Marcum ZA
    authtype: Author
    clusterid: ''
  - name: Huang HC
    authtype: Author
    clusterid: ''
  - name: Romanelli RJ
    authtype: Author
    clusterid: ''
  source: J Gen Intern Med
  pubdate: 2019 Nov
- pmid: '25842792'
  title: Achievement of LDL-cholesterol goal with statins after an st segment elevation
    myocardial infarction.
  authors:
  - name: Tungsubutra W
    authtype: Author
    clusterid: ''
  - name: Phongtuntakul B
    authtype: Author
    clusterid: ''
  source: J Med Assoc Thai
  pubdate: 2015 Feb
- pmid: '36315955'
  title: In ASCVD, moderate-intensity statin + ezetimibe was noninferior to high-intensity
    statin alone at 3 y.
  authors:
  - name: Kelsey MD
    authtype: Author
    clusterid: ''
  - name: Newby LK
    authtype: Author
    clusterid: ''
  source: Ann Intern Med
  pubdate: 2022 Nov
---

# Treat-to-Target LDL Strategy of Statin Dosing Is Noninferior to High-Intensity Dosing.

**Authors:** Slawson, David C

**Published in:** American family physician | Vol. 108, No. 3 | 2023-09-01

**Links:** [PubMed Entry](https://pubmed.ncbi.nlm.nih.gov/37725472/)

## Clinical Information

**Population:** Adults | **Clinical Significance:** High

## Topics & Specialties

**Specialties:** Family Medicine

**Topics:** Family Medicine

## MeSH Terms

Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors

## Article Content

# Treat-to-Target LDL Strategy of Statin Dosing Is Noninferior to High-Intensity Dosing.

**Authors:** Slawson, David C

**Published in:** American family physician | Vol. 108, No. 3 | 2023-09-01

**Links:** [PubMed](https://pubmed.ncbi.nlm.nih.gov/37725472/)

## Clinical Information

**Population:** Adults | **Clinical Significance:** High

## Topics & Specialties

**Specialties:** Family Medicine

**Topics:** Family Medicine

## MeSH Terms

Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors

## Article Content

*Full article content to be extracted and formatted from source material.*

## Additional Resources

- [PubMed Entry](https://pubmed.ncbi.nlm.nih.gov/37725472/) (reference)

---

*Processed: 2025-07-30* | *PubMed Enhanced: 2025-07-30*

## Additional Resources

- [PubMed Entry](https://pubmed.ncbi.nlm.nih.gov/37725472/) (reference)

---

*Processed: 2025-08-09* | *PubMed Enhanced: 2025-07-30*
